Time-restricted eating (TRE), a form of intermittent fasting that limits food intake within a consistent daily window, has gained attention as a feasible strategy to promote metabolic health and align eating with circadian rhythms. Aging and obesity share overlapping pathophysiological mechanisms, including increased visceral adipose tissue (VAT), chronic inflammation, and circadian disruption, which accelerate cardiometabolic decline and multimorbidity. In this Perspective, we examine TRE within a geroscience framework, integrating evidence from human trials and preclinical models to evaluate its potential relevance for aging-related processes. We discuss how the timing of food intake influences VAT distribution and glucose regulation, with early TRE schedules showing particular promise for enhancing nocturnal glycemic control and reducing abdominal subcutaneous adipose tissue. Drawing on circadian biology and caloric restriction literature, we highlight mechanistic insights linking feeding-fasting cycles to autophagy, nutrient sensing, and longevity. We also consider emerging evidence of sex-specific responses to TRE, which may inform personalized approaches. However, most clinical studies remain short-term and focus on cardiometabolic risk markers rather than validated measures of biological aging or functional outcomes. We therefore emphasize the need to distinguish between demonstrated metabolic benefits and proposed gerotherapeutic effects, and argue that future trials should incorporate biomarkers of biological age, circadian robustness, and physiological resilience. TRE represents a low-cost, scalable, and behaviorally simple intervention that could complement existing strategies in geromedicine to extend healthspan and delay age-related decline.